Table 1.
Treatment Guidelines for Patients With Breast Cancer on Aromatase Inhibitor Therapy
DXAT Score | Diagnosis | Recommendations |
---|---|---|
>−1 | Normal | Annual DXA screening Ca++ intake ≥1,200 mg/d Vitamin D intake 400 to 800 IU/d |
−1 to −2.5 | Osteopenia | Consider bisphosphonate therapy if other risk factors present Annual DXA screening Ca++ intake ≥1,200 mg/d Vitamin D intake 400 to 800 IU/d |
≤ −2.5b | Osteoporosis | Initiate bisphosphonate therapy Annual DXA screening Ca++ intake ≥1,200 mg/d Vitamin D Intake 400 to 800 IU/d |
≤ −2.5 (with ≥1 fragility fracture) | Severe osteoporosis | Initiate bisphosphonate therapy Annual DXA screening Ca++ Intake ≥1,200 mg/d Vitamin D Intake 400 to 800 IU/d |